Patent · US Active

FN3 domain-siRNA conjugates and uses thereof

US12239710B2 · kind B2 · utility

0Cited by

58References

57Claims

0Family size

Assignee

ARO Biotherapeutics Company · US

Inventors

Swapnil Kulkarni · Philadelphia, US
Russell C. Addis · Philadelphia, US
Steven G. Nadler · Princeton, US
Yao Xin · Philadelphia, US
Zhanna Druzina · Philadelphia, US
Karyn O'Neil · Spring House, US
Robert Kolakowski · Philadelphia, US
Stephen Anderson · Stonington, US

Key dates

Filing date	Apr 14, 2022
Grant date	Mar 4, 2025
Priority date	—
Expiry date	Apr 14, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to compositions, such as siRNA molecules and FN3 domains conjugated to the same, as well as methods of making and using the molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.